These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 28424198)

  • 1. Pneumococcal Capsular Polysaccharide Immunity in the Elderly.
    Adler H; Ferreira DM; Gordon SB; Rylance J
    Clin Vaccine Immunol; 2017 Jun; 24(6):. PubMed ID: 28424198
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduction of Streptococcus pneumoniae Colonization and Dissemination by a Nonopsonic Capsular Polysaccharide Antibody.
    Doyle CR; Pirofski LA
    mBio; 2016 Feb; 7(1):e02260-15. PubMed ID: 26838726
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pneumococcal Vaccines: Host Interactions, Population Dynamics, and Design Principles.
    Croucher NJ; Løchen A; Bentley SD
    Annu Rev Microbiol; 2018 Sep; 72():521-549. PubMed ID: 30200849
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibodies to Streptococcus pneumoniae capsular polysaccharide enhance pneumococcal quorum sensing.
    Yano M; Gohil S; Coleman JR; Manix C; Pirofski LA
    mBio; 2011; 2(5):. PubMed ID: 21917597
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of 5-valent conjugate pneumococcal protein A - Capsular polysaccharide pneumococcal vaccine against invasive pneumococcal disease.
    Meng C; Lin H; Huang J; Wang H; Cai Q; Fang L; Guo Y
    Microb Pathog; 2009 Sep; 47(3):151-6. PubMed ID: 19467319
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serotype-Independent Protection Against Invasive Pneumococcal Infections Conferred by Live Vaccine With
    Jang AY; Ahn KB; Zhi Y; Ji HJ; Zhang J; Han SH; Guo H; Lim S; Song JY; Lim JH; Seo HS
    Front Immunol; 2019; 10():1212. PubMed ID: 31191555
    [No Abstract]   [Full Text] [Related]  

  • 7. Intranasal Immunization with the Commensal
    Shekhar S; Khan R; Schenck K; Petersen FC
    Appl Environ Microbiol; 2019 Mar; 85(6):. PubMed ID: 30683742
    [No Abstract]   [Full Text] [Related]  

  • 8. Efficacy of opsonic and nonopsonic serotype 3 pneumococcal capsular polysaccharide-specific monoclonal antibodies against intranasal challenge with Streptococcus pneumoniae in mice.
    Tian H; Weber S; Thorkildson P; Kozel TR; Pirofski LA
    Infect Immun; 2009 Apr; 77(4):1502-13. PubMed ID: 19168739
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Pneumococcal Serotype 15C Capsule Is Partially O-Acetylated and Allows for Limited Evasion of 23-Valent Pneumococcal Polysaccharide Vaccine-Elicited Anti-Serotype 15B Antibodies.
    Spencer BL; Shenoy AT; Orihuela CJ; Nahm MH
    Clin Vaccine Immunol; 2017 Aug; 24(8):. PubMed ID: 28637806
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of antibody responses to pneumococcal vaccines with ELISA and opsonophagocytic assay.
    Kim KH; Seoh JY
    J Korean Med Sci; 1999 Oct; 14(5):475-9. PubMed ID: 10576141
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tolerability and immunogenicity of an eleven valent mixed carrier Streptococcus pneumoniae capsular polysaccharide-diphtheria toxoid or tetanus protein conjugate vaccine in Finnish and Israeli infants.
    Dagan R; Kayhty H; Wuorimaa T; Yaich M; Bailleux F; Zamir O; Eskola J
    Pediatr Infect Dis J; 2004 Feb; 23(2):91-8. PubMed ID: 14872172
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative evaluation of a newly developed 13-valent pneumococcal conjugate vaccine in a mouse model.
    Park C; Kwon EY; Choi SM; Cho SY; Byun JH; Park JY; Lee DG; Kang JH; Shin J; Kim H
    Hum Vaccin Immunother; 2017 May; 13(5):1169-1176. PubMed ID: 27960627
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peptide mimics of two pneumococcal capsular polysaccharide serotypes (6B and 9V) protect mice from a lethal challenge with Streptococcus pneumoniae.
    Smith CM; Lo Passo C; Scuderi A; Kolberg J; Baxendale H; Goldblatt D; Oggioni MR; Felici F; Andrew PW
    Eur J Immunol; 2009 Jun; 39(6):1527-35. PubMed ID: 19499518
    [TBL] [Abstract][Full Text] [Related]  

  • 14. L-rhamnose is often an important part of immunodominant epitope for pneumococcal serotype 23F polysaccharide antibodies in human sera immunized with PPV23.
    Park S; Nahm MH
    PLoS One; 2013; 8(12):e83810. PubMed ID: 24391831
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pneumococcal capsular polysaccharide-meningococcal outer membrane protein complex conjugate vaccines: immunogenicity and efficacy in experimental pneumococcal otitis media.
    Giebink GS; Koskela M; Vella PP; Harris M; Le CT
    J Infect Dis; 1993 Feb; 167(2):347-55. PubMed ID: 8421168
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanisms of Naturally Acquired Immunity to
    Ramos-Sevillano E; Ercoli G; Brown JS
    Front Immunol; 2019; 10():358. PubMed ID: 30881363
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nonpneumococcal Strains Recently Recovered from Carriage Specimens and Expressing Capsular Serotypes Highly Related or Identical to Pneumococcal Serotypes 2, 4, 9A, 13, and 23A.
    Gertz RE; Pimenta FC; Chochua S; Larson S; Venero AK; Bigogo G; Milucky J; Carvalho MDG; Beall B
    mBio; 2021 May; 12(3):. PubMed ID: 34006665
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anticapsular serum antibody concentration and protection against pneumococcal colonization among children vaccinated with 7-valent pneumococcal conjugate vaccine.
    Millar EV; O'Brien KL; Bronsdon MA; Madore D; Hackell JG; Reid R; Santosham M
    Clin Infect Dis; 2007 May; 44(9):1173-9. PubMed ID: 17407035
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Agglutination by anti-capsular polysaccharide antibody is associated with protection against experimental human pneumococcal carriage.
    Mitsi E; Roche AM; Reiné J; Zangari T; Owugha JT; Pennington SH; Gritzfeld JF; Wright AD; Collins AM; van Selm S; de Jonge MI; Gordon SB; Weiser JN; Ferreira DM
    Mucosal Immunol; 2017 Mar; 10(2):385-394. PubMed ID: 27579859
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estimating the protective concentration of anti-pneumococcal capsular polysaccharide antibodies.
    Siber GR; Chang I; Baker S; Fernsten P; O'Brien KL; Santosham M; Klugman KP; Madhi SA; Paradiso P; Kohberger R
    Vaccine; 2007 May; 25(19):3816-26. PubMed ID: 17368878
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.